AQP5 has been shown to activate EGFR and consequently to induce the MAPK signaling pathway in several types of cancer, such as glioma [39], lung adenocarcinoma [53,74], colon cancer [38], and also pancreatic cancer [19]. Here, AQP5 is linked to central nervous system cancer.